HEALTH
The Shift in Clinical Trials: Are Patients Really at the Center?
Mon Jun 16 2025
The world of clinical trials is changing fast. The focus is now on putting patients first. This means making sure they stay involved, follow the rules, and want to take part. To do this, more trials are using technology to reach patients where they are. This is called decentralized clinical trials or DCTs. But, is this really making things better for patients?
The idea behind DCTs is to make trials more convenient. Instead of going to a clinic, patients can do some tasks at home. This can save time and money. But, there is a catch. Sometimes, the focus shifts from the patient to the tech. This can make the trial less about the patient's needs and more about getting data quickly.
Think about it. If a patient has to use a complicated app or device, it might not be helpful. It could even make things harder. This is a big problem. The goal should be to help patients, not add more stress.
There is another issue. Not all patients have the same needs. Some might need more help than others. DCTs should be flexible enough to meet these different needs. But, this is not always the case. Sometimes, the tech is one-size-fits-all. This can leave some patients behind.
So, what can be done? First, listen to patients. Ask them what they need and want. Then, use this info to shape the trial. This might mean using simpler tech or offering more support. It could also mean training staff to be more patient-focused.
Remember, the goal is to put patients first. This means more than just using cool tech. It means making sure the trial is helpful and convenient for the patient. It means meeting their needs and making them feel valued. Only then can we say we are truly putting patients at the center.
continue reading...
questions
In what ways do decentralized clinical trials enhance or diminish the patient-centered experience?
Are pharmaceutical companies using decentralized trials to reduce costs at the expense of patient care?
What measures can be taken to ensure that decentralized clinical trials remain patient-centric?
inspired by
actions
flag content